In a filing, Abbott Laboratories revealed its EXECUTIVE VICE PRESIDENT ALLEN HUBERT L unloaded Company’s shares for reported $18.42 million on Oct 21 ’24. In the deal valued at $117.04 per share,157,421 shares were sold. As a result of this transaction, ALLEN HUBERT L now holds 184,806 shares worth roughly $21.08 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ALLEN HUBERT L bought 157,421 shares, generating $18,715,783 in total proceeds.
Before that, Ford Robert B sold 141,679 shares. Abbott Laboratories shares valued at $16,493,218 were divested by the CHAIRMAN AND CEO at a price of $116.41 per share. As a result of the transaction, Ford Robert B now holds 220,059 shares, worth roughly $25.1 million.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock fall -0.13% to $114.07. Over the last five days, the stock has lost -2.50%. Abbott Laboratories shares have risen nearly 3.63% since the year began. Nevertheless, the stocks have risen 21.38% over the past one year. While a 52-week high of $121.64 was reached on 03/08/24, a 52-week low of $91.64 was recorded on 07/18/24. SMA at 50 days reached $114.65, while 200 days put it at $110.55.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 113.47, which if violated will result in even more drops to 112.87. On the upside, there is a resistance level at 114.75. A further resistance level may holdings at 115.43. The Relative Strength Index (RSI) on the 14-day chart is 45.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.87%. Stochastics %K at 29.13% indicates the stock is a holding.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-10-15, growing by 0.62 million shares to a total of 13.98 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 13.36 million shares. There was a rise of 4.42%, which implies that there is a positive sentiment for the stock.
